EUVIMEDEUVIMED entdecken
Open Access

Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C)

Rachel Wong iD, Margaret A Hall, Talia Wiggen, Steven G Johnson, Jared D Huling iD, Lindsey E Turner, Kenneth J Wilkins, Hsin-Chieh Yeh iD, Til Stürmer, Carolyn T Bramante iD, John B Buse, Jane Reusch und 1 weitere

Diabetes Care · 01.10.2024 · 47 (10) · 1846-1854

DOI: 10.2337/dc24-1003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes Care, online erschienen am 29.08.2024. Verfasst von Rachel Wong und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, SARS-CoV-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE The coronavirus 2019 (COVID-19) pandemic has evolved over time by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant, disease severity, treatment, and prevention. There is evidence of an elevated risk of incident diabetes after COVID-19; our objective was to evaluate whether this association is consistent across time and with contemporary viral variants. RESEARCH DESIGN AND METHODS We conducted a retrospective cohort study using National COVID Cohort Collaborative (N3C) data to evaluate incident diabetes risk among COVID-positive adults compared with COVID-negative patients or control patients with acute respiratory illness (ARI). Cohorts were weighted on demographics, data site, and Charlson comorbidity index score. The primary outcome was the cumulative incidence ratio (CIR) of incident diabetes for each viral variant era. RESULTS Risk of incident diabetes 1 year after COVID-19 was increased for patients with any viral variant compared with COVID-negative control patients (ancestral CIR 1.16 [95% CI 1.12–1.21]; Alpha CIR 1.14 [95% CI 1.11–1.17]; Delta CIR 1.17 [95% CI 1.13–1.21]; Omicron CIR 1.13 [95% CI 1.10–1.17]) and control patients with ARI (ancestral CIR 1.17 [95% CI 1.11–1.22]; Alpha CIR 1.14 [95% CI 1.09–1.19]; Delta CIR 1.18 [95% CI 1.11–1.26]; Omicron CIR 1.20 [95% CI 1.13–1.27]). There was latency in the timing of incident diabetes risk with the Omicron variant; in contrast with other variants, the risk presented after 180 days. CONCLUSIONS Incident diabetes risk after COVID-19 was similar across different SARS-CoV-2 variants. However, there was greater latency in diabetes onset in the Omicron variant era.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes MellitusSARS-CoV-2HumansMaleFemaleMiddle AgedRetrospective StudiesAdultIncidenceAgedCohort Studies

Autor:innen und Institutionen

  • Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY.
  • Department of Internal Medicine, Stony Brook University, Stony Brook, NY.
  • Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.
  • Clinical and Translational Science Institute, University of Minnesota, Minneapolis, MN.
  • Institute for Health Informatics, University of Minnesota, Minneapolis, MN.
  • Division of Biostatistics and Health Data Science, School of Public Health, University of Minnesota, Minneapolis, MN.

ORCID-Profile: Rachel Wong, Jared D Huling, Hsin-Chieh Yeh, Carolyn T Bramante

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • NIA NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Wong, R., Hall, M. A., Wiggen, T., Johnson, S. G., Huling, J. D., Turner, L. E., Wilkins, K. J., Yeh, H. C., Stürmer, T., Bramante, C. T., Buse, J. B., Reusch, J., & N3C Consortium (2024). Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C). Diabetes Care, 47(10), 1846-1854. https://doi.org/10.2337/dc24-1003

Vancouver

Wong R, Hall MA, Wiggen T, Johnson SG, Huling JD, Turner LE, et al. Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C). Diabetes Care. 2024;47(10):1846-1854. doi:10.2337/dc24-1003

BibTeX
@article{Wong2024,
  author = {Wong, Rachel and Hall, Margaret A and Wiggen, Talia and Johnson, Steven G and Huling, Jared D and Turner, Lindsey E and Wilkins, Kenneth J and Yeh, Hsin-Chieh and Stürmer, Til and Bramante, Carolyn T and Buse, John B and Reusch, Jane and N3C Consortium, N3C Consortium},
  title = {Effect of SARS-CoV-2 Infection on Incident Diabetes by Viral Variant: Findings From the National COVID Cohort Collaborative (N3C)},
  journal = {Diabetes Care},
  year = {2024},
  volume = {47},
  number = {10},
  pages = {1846--1854},
  doi = {10.2337/dc24-1003}
}
Kostenlos starten →